Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | P/E | P/E vs 5Y | P/S | P/B | EV/EBITDA | P/FCF | FCF yield | Fair value | Margin of safety |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | 130× | +22.8% | 20.0× | 12.3× | 125× | 98.1× | 1.0% | $153.25 | −229% | |
| 2 | $406.97 | −0.96% | $365B | 26.2× | +2.1% | 0.8× | – | 15.9× | 15.5× | 6.5% | – | – | |
| 3 | $250.43 | −4.1% | $256B | 4007× | – | 47.5× | 50.3× | – | 159× | 0.63% | – | – | |
| 4 | $306.08 | −7.3% | $108B | – | – | 19.9× | – | – | 90.3× | 1.1% | – | – | |
| 5 | $840.70 | −8.6% | $75.4B | – | – | 25.0× | 16.2× | 145× | 251× | 0.40% | $138.79 | −506% | |
| 6 | $52.15 | +1.9% | $57.4B | 12.4× | +53.0% | 2.9× | 1.4× | 7.9× | 12.2× | 8.2% | $41.28 | −26.3% | |
| 7 | $258.70 | −10.9% | $44.9B | 128× | – | 37.3× | 26.0× | 153× | 162× | 0.62% | $58.59 | −342% | |
| 8 | $274.37 | −7.4% | $42.9B | 31.5× | +1.6% | 8.6× | 11.6× | 24.3× | 41.9× | 2.4% | $295.83 | +7.3% | |
| 9 | $32.12 | +0.38% | $42.2B | – | – | 1.5× | 3.6× | 18.5× | 32.6× | 3.1% | $26.54 | −21.0% | |
| 10 | $191.31 | +0.55% | $41.0B | – | – | – | 15.7× | – | – | −3.0% | – | – | |
| 11 | $83.63 | −0.82% | $34.3B | 26.5× | – | 3.1× | 4.6× | 9.5× | – | – | $70.73 | −18.2% | |
| 12 | $54.73 | −7.4% | $32.7B | – | – | 42.6× | 9.4× | – | – | −1.1% | $19.05 | −187% | |
| 13 | $54.87 | −9.7% | $30.3B | – | – | 4.0× | 6.0× | 6.6× | – | −45.1% | $22.68 | −142% | |
| 14 | $36.91 | −1.6% | $26.7B | – | – | 3540× | 6.3× | – | – | −3.1% | – | – | |
| 15 | $124.15 | −7.1% | $25.7B | – | – | 16.7× | – | – | 84.7× | 1.2% | – | – | |
| 16 | $73.47 | −1.8% | $24.8B | 13.3× | – | 5.8× | 4.5× | 32.2× | 25.0× | 4.0% | $15.46 | −375% | |
| 17 | $91.73 | −29.2% | $17.6B | 21.3× | – | 6.4× | 5.4× | 18.5× | 17.3× | 5.8% | $101.66 | +9.8% | |
| 18 | $343.12 | −1.6% | $16.4B | – | – | 4.8× | 10.2× | 61.7× | 28.9× | 3.5% | $118.83 | −189% | |
| 19 | $94.39 | −4.5% | $11.6B | – | – | 19.4× | 12.1× | – | 68.6× | 1.5% | $31.71 | −198% | |
| 20 | $21.65 | −3.0% | $11.5B | – | – | 9.0× | 7.8× | – | 49.7× | 2.0% | $6.82 | −218% | |
| 21 | $11.04 | −3.0% | $11.5B | – | – | 1.2× | 1.1× | – | 81.1× | 1.2% | $12.94 | +14.7% | |
| 22 | $57.50 | +1.2% | $11.2B | – | – | 1.8× | 1.5× | 23.7× | – | −11.0% | $38.48 | −49.4% | |
| 23 | $83.53 | −0.64% | $10.8B | – | – | 38.6× | 37.0× | 119× | – | – | $20.67 | −304% | |
| 24 | $77.02 | −1.2% | $10.6B | – | – | 2.3× | 2.3× | 142× | – | – | $60.77 | −26.7% | |
| 25 | $24.30 | −7.2% | $9.9B | – | – | 12.4× | 63.3× | – | – | −0.71% | $3.52 | −591% | |
| 26 | $332.29 | +2.4% | $9.8B | 41.6× | – | 22.3× | 7.2× | 45.5× | 38.2× | 2.6% | $157.63 | −111% | |
| 27 | $110.19 | −1.1% | $9.6B | 19.2× | −29.1% | 7.3× | 2.9× | 8.8× | – | – | $124.79 | +11.7% | |
| 28 | $56.15 | −4.8% | $9.4B | 54.5× | +3.0% | 8.7× | 5.8× | 37.9× | 35.2× | 2.8% | $45.26 | −24.1% | |
| 29 | $30.37 | −1.4% | $9.4B | 21.7× | – | 0.6× | 4.6× | 1.9× | 2.1× | 46.7% | $23.67 | −28.3% | |
| 30 | $61.18 | +5.3% | $9.4B | 22.3× | −67.6% | 11.7× | 15.5× | 69.6× | 539× | 0.19% | $76.21 | +19.7% | |
| 31 | $35.92 | +0.17% | $8.6B | 20.5× | – | 8.4× | 2.2× | – | 37.2× | 2.7% | $20.97 | −71.3% | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | – | – | – | 7.7× | – | – | – | – | – |
| 33 | $53.76 | −0.83% | $8.3B | 8.9× | −5.9% | 2.0× | 4.5× | – | 16.0× | 6.2% | $67.11 | +19.9% | |
| 34 | $28.52 | 0.00% | $8.3B | – | – | – | 3.0× | – | – | – | – | – | |
| 35 | $76.29 | −1.9% | $8.3B | 8.6× | −6.6% | 41.2× | 1.1× | – | – | – | $92.73 | +17.7% | |
| 36 | $41.00 | −1.3% | $7.9B | 20.1× | −4.3% | 8.3× | 1.8× | 9.0× | – | – | $45.20 | +9.3% | |
| 37 | $25.81 | −9.0% | $7.9B | – | – | 5.5× | 13.9× | 33.9× | – | −0.09% | $15.10 | −71.0% | |
| 38 | $23.38 | −1.7% | $7.7B | 24.1× | – | 1.2× | 2.8× | 12.5× | 35.4× | 2.8% | $33.10 | +29.4% | |
| 39 | $110.90 | −3.4% | $7.7B | 30.1× | +93.7% | 1.6× | 2.4× | 12.9× | 19.9× | 5.0% | $96.69 | −14.7% | |
| 40 | $47.81 | −3.8% | $7.6B | 27.3× | −10.1% | 1.4× | 6.8× | 18.7× | – | – | $39.82 | −20.1% | |
| 41 | $65.55 | +1.0% | $7.4B | – | – | 8.8× | – | – | 42.5× | 2.4% | $12.74 | −415% | |
| 42 | $59.40 | −10.6% | $7.3B | – | – | 23.0× | 5.1× | – | – | – | $10.67 | −457% | |
| 43 | $18.34 | −1.1% | $7.2B | 6.8× | – | 0.5× | 1.0× | 4.7× | 8.9× | 11.2% | $47.97 | +61.8% | |
| 44 | $24.34 | +0.12% | $6.9B | – | – | 6.9× | 2.4× | – | – | – | $11.77 | −107% | |
| 45 | $165.13 | −3.8% | $6.8B | 105× | +18.7% | 5.6× | 131× | 71.2× | 26.5× | 3.8% | $71.86 | −130% | |
| 46 | $26.10 | −2.0% | $6.8B | – | – | 8.2× | 5.2× | – | 149× | 0.67% | $12.97 | −101% | |
| 47 | $322.75 | +1.7% | $6.4B | 141× | +244% | 25.3× | 6.7× | 118× | 71.0× | 1.4% | $53.94 | −498% | |
| 48 | $96.87 | +0.23% | $6.4B | – | – | – | 5.8× | – | – | −1.6% | – | – | |
| 49 | $51.31 | +3.3% | $6.3B | 9.1× | −23.5% | 1.6× | 53.8× | 6.5× | 8.4× | 12.0% | $78.19 | +34.4% | |
| 50 | $16.00 | −11.7% | $6.3B | – | – | 0.1× | 3.4× | – | – | −30.2% | – | – |